175 related articles for article (PubMed ID: 9426407)
1. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation.
Hanski C; Riede E; Gratchev A; Foss HD; Böhm C; Klussmann E; Hummel M; Mann B; Buhr HJ; Stein H; Kim YS; Gum J; Riecken EO
Lab Invest; 1997 Dec; 77(6):685-95. PubMed ID: 9426407
[TBL] [Abstract][Full Text] [Related]
2. [Increased methylation of promotor region suppresses expression of MUC2 gene in colon carcinoma cells].
Riede E; Gratchev A; Foss HD; Mann B; Buhr HJ; Hanski C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):299-302. PubMed ID: 14518264
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
5. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.
Ho JJ; Han SW; Pan PL; Deng G; Kuan SF; Kim YS
Int J Oncol; 2003 Feb; 22(2):273-9. PubMed ID: 12527922
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
[TBL] [Abstract][Full Text] [Related]
8. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
9. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation.
Gratchev A; Siedow A; Bumke-Vogt C; Hummel M; Foss HD; Hanski ML; Kobalz U; Mann B; Lammert H; Mansmann U; Stein H; Riecken EO; Hanski C
Cancer Lett; 2001 Jul; 168(1):71-80. PubMed ID: 11368880
[TBL] [Abstract][Full Text] [Related]
11. Alteration in expression of MUC2 and MUC3 mRNA levels in HT29 colonic carcinoma cells.
Mack DR; Hollingsworth MA
Biochem Biophys Res Commun; 1994 Mar; 199(2):1012-8. PubMed ID: 8135773
[TBL] [Abstract][Full Text] [Related]
12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
14. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.
Chen J; Röcken C; Lofton-Day C; Schulz HU; Müller O; Kutzner N; Malfertheiner P; Ebert MP
Carcinogenesis; 2005 Jan; 26(1):37-43. PubMed ID: 15375009
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
Song S; Byrd JC; Mazurek N; Liu K; Koo JS; Bresalier RS
Gastroenterology; 2005 Nov; 129(5):1581-91. PubMed ID: 16285957
[TBL] [Abstract][Full Text] [Related]
17. Mucin gene expression in colonic tissues and cell lines.
Ogata S; Uehara H; Chen A; Itzkowitz SH
Cancer Res; 1992 Nov; 52(21):5971-8. PubMed ID: 1394223
[TBL] [Abstract][Full Text] [Related]
18. Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues.
Kim BN; Yamamoto H; Ikeda K; Damdinsuren B; Sugita Y; Ngan CY; Fujie Y; Ogawa M; Hata T; Ikeda M; Ohue M; Sekimoto M; Monden T; Matsuura N; Monden M
Int J Oncol; 2005 May; 26(5):1217-26. PubMed ID: 15809712
[TBL] [Abstract][Full Text] [Related]
19. Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma.
Babidge WJ; Butler LM; Burton MA; Cowled PA
Anticancer Res; 2001; 21(4A):2809-14. PubMed ID: 11724359
[TBL] [Abstract][Full Text] [Related]
20. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.
Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM
Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
